In the recent years, circulating microRNAs (miRNAs) have garnered a lot of attention and
interest in the field of disease biomarkers. With characteristics such as high stability, low cost, …

Treating patients who have cancer with vaccines that stimulate a targeted immune response
is conceptually appealing, but cancer vaccine trials have not been successful in late-stage …

Genome-wide association studies (GWAS) and fine-mapping efforts to date have identified
more than 100 prostate cancer (PrCa)-susceptibility loci. We meta-analyzed genotype data …

To further dissect the genetic architecture of colorectal cancer (CRC), we performed whole-genome
sequencing of 1,439 cases and 720 controls, imputed discovered sequence variants …

Most common breast cancer susceptibility variants have been identified through genome-wide
association studies (GWAS) of predominantly estrogen receptor (ER)-positive disease 1 . …

In recent years, circulating miRNAs have attracted a great deal of attention as promising novel
markers for various diseases. Here, we investigated their potential to serve as minimally …

Lung cancer (LC) is a leading cause of cancer‐related death in the Western world. Patients
with LC usually have poor prognosis due to the difficulties in detecting tumors at early stages…

Purpose: The use of circulating tumor cells (CTC) as a prognostic marker in metastatic breast
cancer (MBC) has been well established. However, their efficacy and accuracy are still …

Background: Lung cancer (LC) is the leading cause of cancer-related death in Eastern Asia.
The prognosis of LC highly depends on tumor stages and early detection could substantially …

Circulating or cell-free DNA (cfDNA) has been evaluated as a biomarker in many cancers
including breast cancer. In particular, integrity of cfDNA has been shown to be altered in …